Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: November 2025 (Report No. 3)
Date of Filing: November 14, 2025
Context: The filing serves to notify the SEC of a press release issued on November 14, 2025, regarding the receipt of a Nasdaq Minimum Bid Price Notification.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate event and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The sole material event disclosed is the receipt of a notification from Nasdaq regarding the company's stock failing to meet the minimum bid price requirement.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release titled "IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification."
Risks and Contingencies: The receipt of a Nasdaq Minimum Bid Price Notification indicates a risk of potential delisting if the company fails to regain compliance with Nasdaq listing standards within the specified timeframe. No specific guidance or outlook regarding future financial performance is provided in this text.
Investor Verification Checklist
- Verify the specific terms and compliance timeline outlined in the Nasdaq Minimum Bid Price Notification.
- Review the full text of the press release (Exhibit 99.1) for details on the company's proposed plan to regain compliance.
- Monitor subsequent filings for updates on the stock price and compliance status.
- Check the company's most recent Form 20-F for the latest audited financial data, as this 6-K contains no financial figures.